title: Pulmonary epithelioid haemangioendothelioma and bevacizumab.
authors.forename: Laure
authors.initials: L
authors.lastname: Belmont
authors.forename: Leila
authors.initials: L
authors.lastname: Zemoura
authors.forename: Louis Jean
authors.initials: LJ
authors.lastname: Couderc
mesh_terms: D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000068258:Bevacizumab; D018323:Hemangioendothelioma, Epithelioid / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D014057:Tomography, X-Ray Computed
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab